Cargando…
Assessing quality of life of idiopathic pulmonary fibrosis patients: the INSTAGE study
The addition of sildenafil to nintedanib treatment does not improve outcomes to a greater extent than monotherapy with nintedanib, and it is not recommended for IPF subjects http://ow.ly/Gaq530o9kEg
Autores principales: | Suarez-Cuartin, Guillermo, Molina-Molina, Maria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6544796/ https://www.ncbi.nlm.nih.gov/pubmed/31191729 http://dx.doi.org/10.1183/20734735.0016-2019 |
Ejemplares similares
-
Clinical implications of ANCA positivity in idiopathic pulmonary fibrosis patients
por: Suarez-Cuartin, Guillermo, et al.
Publicado: (2020) -
Acute exacerbations of idiopathic pulmonary fibrosis and the role of corticosteroids
por: Brereton, Christopher J., et al.
Publicado: (2020) -
Treatment of pulmonary hypertension in idiopathic pulmonary fibrosis: shortfall in efficacy or trial design?
por: Nathan, Steven D, et al.
Publicado: (2014) -
Quality of life assessment in clinical research on Chinese medicine: Early experience and outlook
por: Wong, Lai Yi Eliza, et al.
Publicado: (2008) -
Management of severe and rigid idiopathic scoliosis
por: Teixeira da Silva, Luis Eduardo Carelli, et al.
Publicado: (2015)